Evidence map›Paper›PMID 33426772›Full record

ArticleCancer science2021

Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.

Shugo Sakihama, Kazuho Morichika, Rumiko Saito, Megumi Miyara, Takashi Miyagi, Masaki Hayashi, Junnosuke Uchihara, Takeaki Tomoyose, Kazuiku Ohshiro, Shingo Nakayama and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Shugo SakihamaDepartment of Pathology and Cell Biology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.ORCID https://orcid.org/0000-0002-2411-2539
Kazuho MorichikaDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
Rumiko SaitoLife Science Analytic Center, Life Science Business Office, Corporate Technology Planning Division, Toshiba Corporation, Sendai, Japan.
Megumi MiyaraFaculty of Health and Nutrition, Okinawa University, Naha, Japan.
Takashi MiyagiDepartment of Hematology, Heartlife Hospital, Nakagusuku, Japan.
Masaki HayashiDepartment of Hematology, Nakagami Hospital, Okinawa, Japan.
Junnosuke UchiharaDepartment of Hematology, Naha-City Hospital, Naha, Japan.
Takeaki TomoyoseDepartment of Hematology, Okinawa Red Cross Hospital, Naha, Japan.
Kazuiku OhshiroDepartment of Hematology & Oncology, Okinawa Prefectural Nanbu Medical Center & Children's Medical Center, Haebaru, Japan.
Shingo NakayamaFaculty of Medicine, University of the Ryukyus, Nishihara, Japan.
Sawako NakachiDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.
Satoko MorishimaDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.ORCID https://orcid.org/0000-0002-7391-4271
Kazuko SakaiDepartment of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.ORCID https://orcid.org/0000-0003-1822-2720
Kazuto NishioDepartment of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.ORCID https://orcid.org/0000-0002-8275-0846
Hiroaki MasuzakiDivision of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.ORCID https://orcid.org/0000-0002-2445-1047
Takuya FukushimaLaboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Japan.
Kennosuke KarubeDepartment of Pathology and Cell Biology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.ORCID https://orcid.org/0000-0002-1205-858X
University of the Ryukyus · JPKindai University · JPNaha City Hospital · JPGunma Children's Medical Center · JPHeart Life Hospital · JPOkinawa Red Cross Hospital · JPOkinawa University · JPToshiba (Japan) · JP

Funding

Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical CareJapanese Society of Hematology research grantJapan Leukemia Research FundJapan Society for the Promotion of Science JP19K07438Japan Society for the Promotion of Science JP19K17835Life Medicine Research Promotion FoundationOkinawa Internal Medicine Research Promotion SocietyOkinawa PrefectureYasuda Memorial Medical Foundation
6 · The paper itself

Abstract

Genetic alterations in adult T-cell leukemia/lymphoma (ATLL), a T-cell malignancy associated with HTLV-1, and their clinical impacts, especially from the perspective of viral strains, are not fully elucidated. We employed targeted next-generation sequencing and single nucleotide polymorphism array for 89 patients with ATLL in Okinawa, the southernmost islands in Japan, where the frequency of HTLV-1 tax subgroup-A (HTLV-1-taxA) is notably higher than that in mainland Japan, where most ATLL cases have HTLV-1-taxB, and compared the results with previously reported genomic landscapes of ATLL in mainland Japan and the USA. Okinawan patients exhibited similar mutation profiles to mainland Japanese patients, with frequent alterations in TCR/NF-ĸB (eg, PRKCB, PLCG1, and CARD11) and T-cell trafficking pathways (CCR4 and CCR7), in contrast with North American patients who exhibited a predominance of epigenome-associated gene mutations. Some mutations, especially GATA3 and RHOA, were detected more frequently in Okinawan patients than in mainland Japanese patients. Compared to HTLV-1-taxB, HTLV-1-taxA was significantly dominant in Okinawan patients with these mutations (GATA3, 34.1% vs 14.6%, P = .044; RHOA, 24.4% vs 6.3%, P = .032), suggesting the contribution of viral strains to these mutation frequencies. From a clinical viewpoint, we identified a significant negative impact of biallelic inactivation of PRDM1 (P = .027) in addition to the previously reported PRKCB mutations, indicating the importance of integrated genetic analysis. This study suggests that heterogeneous genetic abnormalities in ATLL depend on the viral strain as well as on the ethnic background. This warrants the need to develop therapeutic interventions considering regional characteristics.

Indexed as

Genetic ProfileAdultAgedAged, 80 and overBiomarkers, TumorDNA Copy Number VariationsEthnicityFemaleFollow-Up StudiesGene Products, taxGenotyping TechniquesHigh-Throughput Nucleotide SequencingHTLV-I InfectionsHumansHuman T-lymphotropic virus 1JapanBiomarkers, TumorGene Products, taxadult T-cell leukemia/lymphomageographical mutation heterogeneityhuman T-cell leukemia virus type Iintegrated clinico-genetic analysistax subgroup

Identifiers

PMID33426772
PMCPMC7935801
OpenAlexW3120929554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.